Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hilliquin, P.
Right arrow Articles by Menkès, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hilliquin, P.
Right arrow Articles by Menkès, C. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2000; 39: 1020-1026
© 2000 British Society for Rheumatology

Reduced incidence and prevalence of atopy in rheumatoid arthritis. Results of a case–control study

P. Hilliquin, Y. Allanore, J. Coste1, M. Renoux, A. Kahan and C. J. Menkès

Service de Rhumatologie A and
1 Département d’Informatique Médicale, Hôpital Cochin, Paris, France

Objective. To determine the cumulative incidence and the point prevalence of atopy in patients with rheumatoid arthritis (RA).

Patients and methods. A standardized questionnaire was sent to 300 RA patients. Questions concerned previous or present characteristics of atopy (hay fever, asthma and constitutive eczema) and RA. RA patients were matched with genetically unrelated controls (sister- or brother-in-law, neighbour or friend). The same questionnaire (except for questions about RA) was sent to the control subjects. In cases of atopy, patients, controls and the treating physicians were contacted by a physician to check the validity of the responses.

Results. Paired responses were obtained in 173 cases. Information about atopy was obtained for 69 other RA patients. The characteristics of RA were similar for patients who responded and those who did not respond. The frequency of atopy was significantly lower in RA patients than in controls, both for cumulative incidence (RA 7.5%, controls 18.8%; P < 0.01) and point prevalence (RA 3.5%, controls 16.2%; P < 0.0001). The clinical manifestations of atopy stopped before the onset of RA in eight of the 17 RA patients with an allergic condition, and there was no subsequent relapse. No effect of RA treatment could account for the remission of atopy.

Conclusion. These data support the concept that atopy protects against the future development of RA and that the two diseases could counterbalance one another.

KEY WORDS: Atopy, Hay fever, Asthma, Rheumatoid arthritis.

Correspondence to: C. J. Menkès, Service de Rhumatologie A, Hôpital Cochin, 27 rue du Faubourg Saint-Jacques, 75679 Paris Cedex 14, France.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Ann Rheum DisHome page
G Provenzano, G Donato, G Brai, and F Rinaldi
Prevalence of allergic respiratory diseases in patients with RA
Ann Rheum Dis, March 1, 2002; 61(3): 281 - 281.
[Full Text] [PDF]


Home page
Eur Respir JHome page
M. Roponen, J. Kiviranta, M. Seuri, H. Tukiainen, R. Myllykangas-Luosujarvi, and M-R. Hirvonen
Inflammatory mediators in nasal lavage, induced sputum and serum of employees with rheumatic and respiratory disorders
Eur. Respir. J., September 1, 2001; 18(3): 542 - 548.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.